70P Impact of TP53/KRAS mutations on overall survival of metastatic non-small cell lung cancer patients (pts) treated with systemic first-line therapy

Autor: Novella, S. Rubio, Cobo, A., Montes, A., Lopez, J. Soler, Rondan, M. Arnal, Palanca, S. Noguera, Tena, I., Miguel, J., Navarro, B., Domingo, I., Esteban, S. Cases, Díaz, M., Andrade, P., Rosello, E., Santander, J.R. Lazaro, Estelles, D. Lorente, Hernández, A. Sánchez
Zdroj: In Journal of Thoracic Oncology April 2023 18(4) Supplement:S80-S81
Databáze: ScienceDirect